Page breadcrumb nav

VAERS Report 2156707

Case Report Section

Détails du rapport Vaer

Âge: 43 ans

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: fl9994


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2022-02-12
Date d’apparition
0
Nombre de jours (date d’apparition – date de vaccination)
0
Description de l’événement indésirable

lymph nodes enlarged/ lymph under left armpit is swollen; unable to lie on the left arm; patient received first and second dose of non-pfizer covid-19 vaccine and booster dose of comirnaty; patient received first and second dose of non-pfizer covid-19 vaccine and booster dose of comirnaty; skin pain; joint pain; muscle ache; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory agency. the reporter is the patient. regulatory number: gb-mhra-webcovid-202202141248504500-xmeol. other case identifier(s): gb-mhra-adr 26601290. a 43 year-old female patient (not pregnant) received bnt162b2 (comirnaty), administered in arm left, administration date 12feb2022 09:30 (lot number: fl9994) at the age of 43 years as dose 3 (booster), single for covid-19 immunisation. the patient had no relevant medical history. there were no concomitant medications. patient had not had symptoms associated with covid-19. patient was not pregnant and was not currently breastfeeding. vaccination history included: covid-19 vaccine (dose 2, manufacturer unknown), for covid-19 immunisation; covid-19 vaccine (dose 1, manufacturer unknown), for covid-19 immunisation. the following information was reported: off label use (medically significant), interchange of vaccine products (medically significant) all with onset 12feb2022, outcome "unknown" and all described as "patient received first and second dose of non-pfizer covid-19 vaccine and booster dose of comirnaty"; lymphadenopathy (medically significant) with onset 13feb2022, outcome "not recovered", described as "lymph nodes enlarged/ lymph under left armpit is swollen"; pain of skin (medically significant) with onset 12feb2022, outcome "recovering", described as "skin pain"; arthralgia (medically significant) with onset 12feb2022, outcome "recovering", described as "joint pain"; myalgia (medically significant) with onset 12feb2022, outcome "recovering", described as "muscle ache"; limb discomfort (medically significant) with onset 12feb2022 12:00, outcome "unknown", described as "unable to lie on the left arm". the patient underwent the following laboratory tests and procedures: sars-cov-2 test: negative. therapeutic measures were taken as a result of lymphadenopathy, pain of skin, arthralgia, myalgia, limb discomfort. clinical course: the patient took the vaccine at 9:30am and had no effects until 12am when she was unable to lie on the left arm where she took the vaccine. the whole of her left side was painful, the skin, the joints and muscles. lymph under left armpit was swollen. she had been taken 2 tablets of paracetamol since sunday 13feb2022 every 4 hours. patient had not tested positive for covid-19 since having the vaccine and was not enrolled in clinical trial. no follow-up attempts are possible. no further information is expected

Données de laboratoire
test name: covid-19 virus test; test result: negative
Liste des symptômes
arthralgia lymphadenopathy myalgia interchange of vaccine products sars-cov-2 test limb discomfort off label use pain of skin
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na